Skip to main content
. 2016 Jul 21;18(9):832–839. doi: 10.1111/jch.12877

Table 3.

Included Studies

Author Country Outcome Population Intervention/Follow‐Up Measurement Method Results Comments
Surrogate markers (one RCT)
Amer et al27 United States Headache 390 participants with prehypertension or stage one hypertension aged ≥22 y Three levels of dietary sodium intake and two diet patterns (the DASH diet and a control diet). Three 30‐day periods, each at “high” sodium diet with 8.6 g salt (sodium 3400 mg)/d, “intermediate” sodium diet with 5.75 g salt (sodium 2300 mg)/d, and “low” sodium diet with 2.8 g salt (sodium 1120 mg)/d 24‐h urinary sodium excretion; self‐administered questionnaire to assess severity of headache Lower risk of headache on the “low” sodium diet with 2.8 g salt (sodium 1120 mg)/d, compared with “high” sodium diet with 8.6 g salt (sodium 3400 mg)/d, both on the control (OR, 0.69; 95% CI, 0.49–0.99; P=.05) and the DASH (OR, 0.69; 95% CI, 0.49–0.98; P=.04) diets No significant association of diet pattern (DASH vs control) with headache on any sodium level. Headaches not a hard outcome
Substantive patient outcomes (two cohort, one systematic review and meta‐analysis, and one meta‐analysis [total of four studies])
Singer et al28 United States All‐cause mortality; cardiovascular mortality 3505 hypertensive participants Follow‐up of 18.6 y 24‐h urinary sodium excretion There was a significant association between sodium and all‐cause mortality (Q1 vs Q4: HR, 0.81; 95%, CI, 0.66–1.00; P=.05). A significant association between dietary sodium and noncardiovascular mortality (Q1 vs Q4 ratio: HR, 0.57; 95% CI, 0.42–0.80; P=.001) Exposure was only assessed at baseline.
Poggio et al29 Japan, United States, Belgium, Scotland, the Netherlands, and Finland Cardiovascular mortality 229,785 participants Average follow‐up period of 13.37 y (range 5.5–19 y) Different methods used for assessment of sodium intake (24‐h urine, 24‐h dietary recall, food Frequency questionnaire and 3‐d dietary record) There was a significant association between higher sodium intake and cardiovascular mortality (RR, 1.12; 95% CI, 1.06–1.19). Every increase of sodium 0.57 salt (sodium 230 mg)/d in sodium intake, CVD mortality increased by 1% (P=.016)

Abbreviations: CI, confidence interval; CVD, cardiovascular disease; DASH, Dietary Approaches to Stop Hypertension; HR, hazard ratio; OR, odds ratio; Q, quartile; RCT, randomized controlled trial; RR, relative risk.